Get the Stockscreener App
46.70
5.16%
-2.54
ARK Genomic Revolution ETF stock is traded at $46.70, with a volume of 9.84M.
It is down -5.16% in the last 24 hours and down -2.40% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$49.24
Open:
$49.36
24h Volume:
9.84M
Relative Volume:
1.42
Market Cap:
$1.98B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-8.97%
1M Performance:
-2.40%
6M Performance:
+56.50%
1Y Performance:
+45.57%
1-Day Range:
$46.41
$49.54
1-Week Range:
$46.41
$51.11
52-Week Range:
$24.60
$58.83
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
46.70 | 1.98B | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
701.61 | 1.03T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
766.67 | 879.75B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
763.25 | 806.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
374.07 | 688.96B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
709.80 | 474.71B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Cathie Wood's ARK Invest Dumps $9.4 Million in SpaceX, Rotates Into AI and Air Taxis - BigGo Finance
5 Surging ETFs Up More than 50% in 2026 - TIKR.com
Cathie Wood's ARK Invest Rotates $22 Million in Biotech, Extends Intellia Buying Streak to 50 Sessions - BigGo Finance
Cathie Wood Dumps $18M Twist, Bets On CRISPR, AI Drug DiscoveryARK Genomic Revolution ETF (BATS:ARKG) - Benzinga
UmweltBank-ETF-Eur.SDG Focus A (FFJ7G.DE) risk - Yahoo Finance UK
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares - Yahoo Finance
State Street SPDR Bloomberg 0-3 Year U.S. Corporate Bond UCITS ETF (SYBF.F) interactive stock chart - Yahoo Finance Australia
iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) options chain - Yahoo Finance Australia
MUL Amundi EUR GovBond 7-10Y U (MTDD.DU) interactive stock chart - Yahoo Finance UK
Xtr-MSCI Wld Min.Vola.ESG ETF R (XWEB.HA) - Yahoo Finance Singapore
These 2 Cathie Wood Biotech Bets Are Up Nearly 6X — But Retail Still Isn’t Sold On One - Stocktwits
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year - TradingView
Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year - Yahoo Finance
Discipline and Rules-Based Execution in ARKG Response - Stock Traders Daily
ARK Genomic Revolution ETF (ARKG) stock price, news, quote and history - Yahoo Finance Australia
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You - Yahoo Finance
Cathie Wood Doubles Down on Elon Musk-Linked Stocks - TradingView
ETFs Investing in Generate Biomedicines, Inc. Stocks - TradingView
Elon Musk led Tesla, SpaceX take center stage in Cathie Wood’s Ark portfolio - TradingView
Elon Musk led Tesla, SpaceX take center stage in Cathie Wood’s Ark portfolio (ARKK:BATS) - Seeking Alpha
ETFs Investing in Personalis, Inc. Stocks - TradingView
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You - Benzinga
4 Best ETF Areas of Q3 That Are in High Momentum - TradingView
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) - Seeking Alpha
Weekly Recap: Decipher studies at ASTRO 2026 and ARKG buys Veracyte, Inc. - TradingView
Technical Reactions to ARKG Trends in Macro Strategies - Stock Traders Daily
Technical Reactions to ARKG Trends in Macro Strategies - Stock Traders Daily
ARKG Top Holdings List & Exposure (ARK Genomic Revolution ETF) - MarketBeat
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets - Benzinga
ARKG 260925 44.00C (ARKG260925C44000) Stock Community & Discussion - moomoo.com
How Cathie Wood's Fund Gave Us A Back Door To Moderna's Breakthrough - Investor's Business Daily
Cathie Wood’s ARK adds Intellia stock, trims Brera Holdings By Investing.com - Investing.com South Africa
Cathie Wood Just Went Bargain Hunting. Here Are the 3 AI Stocks She Bought. - The Globe and Mail
Cathie Wood Just Went Bargain Hunting. Here Are the 3 AI Stocks She Bought. - Yahoo Finance
Cathie Wood Just Went Bargain Hunting. Here Are the 3 AI Stocks She Bought. - The Motley Fool
ARK genomics UCITS ETF jumps 27% in a month as annual gain nears 100% - QuotedData
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Cathie Wood's Ark Has Delivered Just a 13.8% Annualized Return Since 2014, Roughly Matching the S&P 500. Should You Trust Her Bold Predictions for 2030? - The Motley Fool
⚡ Cathie Wood On Tesla Stock & Market Bubbles (Supercut) Childcare (vqEHAKRzD2) - Mshale
Cathie Wood’s ARK Invest Adds Robinhood & Solana ETF, Trims Biotech Stocks - The Crypto Times
🚀 LOADING UP! Revealing Cathie Wood's Biggest Moves In ARK Invest's HIGH GROWTH ETFs (Deep Dive) Ajay Mitchell (CIqnM45xDB) - Mshale
Cathie Wood’s ARK buys Intellia stock, sells Brera holdings By Investing.com - Investing.com Australia
How Ark Genomic Revolution Etf (ARKG) Affects Rotational Strategy Timing - Stock Traders Daily
The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFsModerna (NASDAQ:MRNA) - Benzinga
Best-Performing ETF Areas of August - tradingview.com
What Is Cathie Wood Buying Now? Nvidia, SpaceX And Crypto Stocks Led ARK’s August Trades – While Cutting These Growth Stocks - TradingView
Cathie Wood's ARK Buys Over $40M in Block and Circle as USDC's Chelsea Kit Debuts, One Down and One Up 9.65% - The Crypto Times
Ark Invest Goes Against the Grain: Wood Bets on Nvidia and the Gene-Editing Arena - NAI500
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Cathie Wood's Ark weekly recap: boosts NVDA, AVGO as AMD leads sales (ARKK:BATS) - Seeking Alpha
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):